Skip to main content
. 2023 May 12;14:1186841. doi: 10.3389/fmicb.2023.1186841

Figure 2.

Figure 2

Killing curve of SAR-R and clinical drug-resistant Salmonella. (A) Percent survival curve of sarafloxacin (1MIC) and L-leucine (20 mM) action on four drug-resistant bacteria in M9 Minimal medium. (B) Percent survival curve of different concentrations of L-leucine (0, 5, 10, 20 mM) combined with sarafloxacin (1MIC) on SAR-R in M9 Minimal medium. (C) Growth promotion curve of glucose (40 mM) on SAR-R in M9 Minimal medium. (D) Percent survival curve of sarafloxacin (1MIC) and glucose (40 mM) action on SAR-R in M9 Minimal medium. Results are displayed as the mean ± SEM and three biological repeats are carried out.